Side Effects of gemfibrozil: A Synthesis of Findings from 27 Studies
- Home
- Side Effects of gemfibrozil
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of gemfibrozil: A Synthesis of Findings from 27 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Gemfibrozil is a drug used to treat high triglycerides, and 12 reported that it has antidepressant effects in mice. 2 also states that gemfibrozil is an agonist of peroxisome proliferator-activated receptor-α (PPARα) and is used as an adjunct therapy in the treatment of diabetes mellitus. Additionally, 4 introduced gemfibrozil as one of the drugs used in the treatment of dyslipidemia.
Reasons for Side Effects
Side effects of gemfibrozil may be related to its mechanism of action and drug interactions. 7 suggests that gemfibrozil may impair mitochondrial function. 14 points out that the risk of rhabdomyolysis may be increased when gemfibrozil is used concomitantly with statins.
Common Side Effects
Gastrointestinal
8 , 1 , 20 , 10 report gastrointestinal symptoms such as gastrointestinal discomfort, nausea, and vomiting. 20 also reports a risk of cholelithiasis and cholecystitis.
Musculoskeletal
3 , 11 , 5 , 16 , 24 , 14 report side effects such as muscle pain, weakness, and rhabdomyolysis. 24 suggests that gemfibrozil may cause skeletal muscle metabolic impairment in patients with chronic renal failure.
Hepatic
11 , 3 report a risk of liver dysfunction and hepatitis. 20 also states that gemfibrozil may elevate liver enzymes.
Others
12 suggests that the antidepressant effect in mice is mediated by the activation of the brain-derived neurotrophic factor (BDNF) signaling pathway. 1 reports polyuria as a side effect. 15 reports epigastric pain and burning as side effects of gemfibrozil. 13 suggests that gemfibrozil enhances reactive oxygen metabolism in phagocytes. 22 reports that gemfibrozil improves lipid metabolic abnormalities in patients on continuous ambulatory peritoneal dialysis (CAPD).
Measures for Side Effects
Gastrointestinal
If you experience gastrointestinal side effects, dietary and lifestyle changes may be helpful. For example, avoiding fatty foods and eating small, frequent meals can be beneficial. Taking appropriate medications as directed by your doctor can also be effective.
Musculoskeletal
If you experience muscle pain, it is important to rest and reduce physical activity. Consulting with your doctor and taking medication if necessary can also help. If you experience serious side effects such as rhabdomyolysis, you should immediately seek medical attention.
Hepatic
If you experience liver dysfunction, you will need to have regular blood tests to monitor your liver function as directed by your doctor. You should also refrain from alcohol consumption.
Comparison Between Studies
Similarities
Multiple studies have consistently shown that gemfibrozil affects lipid metabolism. Additionally, gemfibrozil is used as a treatment for hypertriglyceridemia and dyslipidemia.
Differences
Several studies have shown different results regarding the side effects of gemfibrozil. For example, 14 reports an increased risk of rhabdomyolysis when gemfibrozil is used in combination with statins, but other studies do not mention this side effect. There are also varying results regarding the efficacy of gemfibrozil. For example, 12 reports that gemfibrozil exhibits antidepressant effects in mice, but other studies do not mention this effect.
Notes on Real-World Application
While gemfibrozil is a drug used to treat hypertriglyceridemia and dyslipidemia, it is important to be aware of the potential risks of side effects. If you experience muscle pain or rhabdomyolysis, you should consult with your doctor immediately. Gemfibrozil may also interact with other medications, so be sure to talk to your doctor before taking it.
Limitations of Current Research
Research on gemfibrozil is still considered insufficient. Further studies are necessary to determine long-term safety and efficacy. The mechanisms by which gemfibrozil causes side effects are not fully understood.
Future Research Directions
Future research on gemfibrozil should focus on clarifying long-term safety and efficacy, elucidating the mechanisms of side effect occurrence, and identifying optimal dosage regimens and combination therapies to maximize efficacy and minimize side effects.
Conclusion
Gemfibrozil is a drug used to treat hypertriglyceridemia and dyslipidemia that offers potential benefits. However, it is essential to understand the risks of side effects. If you are considering taking gemfibrozil, consult with your doctor and receive an appropriate prescription.
Benefit Keywords
Risk Keywords
Article Type
Author: AhmedAshraf Oe, OkotchaEdmond, SaadAbdul-Hussein
Language : English
Author: AdeghateErnest, AdemAbdu, HasanMohamed Y, TekesKornelia, KalaszHuba
Language : English
Author: WhayneThomas F
Language : Spanish
Author: LipsyRobert J
Language : English
Author: AthyrosVasilios G, PapageorgiouAthanasios A, AthyrouValasia V, DemitriadisDimokritos S, PehlivanidisAnthimos N, KontopoulosAthanasios G
Language : English
Author: DucobuJean, ScheenAndré, Van GaalLuc, VelkeniersBrigitte, HermansMichel
Language : English
Author: NadanacivaSashi, DykensJames A, BernalAutumn, CapaldiRoderick A, WillYvonne
Language : English
Author: WangJ J, SongY M, WangY S, LinW H
Language : Chinese
[Comparison of the efficacy between simvastatin and gemfibrozil in primary hypercholesterolemia].
Author: LecerfJ M, LucG, BaigtsF, DevulderB
Language : French
Author: LuZ L
Language : Chinese
Author: MoghadasianMohammed H
Language : English
Author: NiYu-Fei, WangHao, GuQiu-Yan, WangFei-Ying, WangYing-Jie, WangJin-Liang, JiangBo
Language : English
Author: ScatenaR, NoccaG, De SoleP, FresuR, ZuppiC, GiardinaB
Language : English
Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil.
Author: van PuijenbroekE P, Du Buf-VereijkenP W, SpoorenP F, van DoormaalJ J
Language : English
Author: SimoniG, GianottiA, ArdiaA, BaiardiA, CivalleriD
Language : English
Author: ShammasNicholas W, KapalisMatthew J, DeckertJudi, HarrisMelodee, DippelEric J, LabrooAjay, McKinneyDawn
Language : English
Author: TalpurRakhshandra, WardStaci, ApisarnthanaraxNarin, Breuer-MchamJoan, DuvicMadeleine
Language : English
Language : English
Author: WiklundO, AngelinB, BergmanM, BerglundL, BondjersG, CarlssonA, LindénT, MiettinenT, OdmanB, OlofssonS O
Language : English
Author: TurkoskiBeatrice B
Language : English
Author: SnyderS
Language : English
Author: ChanM K
Language : English
Author: JoverE, ArandaJ L, NoguésX, del PalacioA, Rubiés-PratJ
Language : Spanish
Author: ThompsonC H, IrishA, KempG J, TaylorD J, RaddaG K
Language : English
Author: FaergemanO
Language : English
Author: WangShuyi, GunschClaudia K
Language : English
Author: MirhosseiniMahmoud, BaradaranAzar, Rafieian-KopaeiMahmoud
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.